Long-term Survival of Personalized Surgical Treatment of Locally Advanced Non-small Cell Lung Cancer Based on Molecular Staging

Long-term Survival of Personalized Surgical Treatment of Locally Advanced Non-small Cell Lung Cancer Based on Molecular Staging

Background and objective Approximately 35%-40% of patients with newly diagnosed non-small cell Lung cancer have locally advanced disease. The average survival time of these patients only have 6-8 months with chemotherapy. The aim of this study is to explore and summarize the probability of detection...

Full description

Bibliographic Details
Main Authors: Qinghua ZHOU, Yingkang SHI, Jun CHEN, Bin LIU, Yun WANG, Daxing ZHU, Hong-Tao ZHANG, Peng XU, Youling GONG, Gang CHEN, Sen WEI, Xiaoming QIU, Zhongxi NIU, Xiaofeng CHEN, Zhe LEI, Liang DUAN, Zhu WU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Locally advanced non-small cell lung cancer
Micrometastasis molecular diagnosis
Molecular staging
Personalized surgical treatment
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.02.15&path[]=3612

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.02.15&path[]=3612

Similar Items